Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review

Affiliations

• ¹ Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
• ² CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
• ³ Department of Health Sciences and Technology, Harvard-MIT, Cambridge, MA, USA.
• ⁴ Tufts University School of Medicine, Boston, MA, USA.
• ⁵ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
• ⁶ Countway Library of Medicine, Harvard Medical School, Boston, MA, USA.
• ⁷ Beth Israel Deaconess Medical Center, Boston, MA, USA.
• ⁸ GlaxoSmithKline, Durham, NC, USA.
• ⁹ GlaxoSmithKline, Brentford, UK.
• ¹⁰ Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, University of London, London, UK.
• ¹¹ Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
• ¹² Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.
• ¹³ CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.
• ¹⁴ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.